AlphaGrep UK Ltd’s Abbott ABT Stock Holding History

AlphaGrep UK Ltd’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$789K	Buy	7,685 +5,536	+258%	+$625K	0.23%	77
2025 Q4	$269K	Buy	+2,149	New	+$274K	0.09%	489

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AlphaGrep UK Ltd's ABT Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Abbott (ABT) stake by 258% in Q1 2026, buying an estimated $625K and bringing the position to 7,685 shares worth $789K. The position accounts for 0.23% of the portfolio, ranked #77.

AlphaGrep UK Ltd first reported a position in ABT in Q4 2025 and has held it in 2 quarters since. 3,102 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

AlphaGrep UK Ltd held 7,685 shares of Abbott worth $789K as of Q1 2026.
AlphaGrep UK Ltd bought 5,536 Abbott shares in Q1 2026, an estimated $625K.
Abbott made up 0.23% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #77 holding.
AlphaGrep UK Ltd first reported a position in Abbott in Q4 2025 and has held it in 2 quarters since.
3,102 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.